XML 11 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 6,029,964 $ 4,763,364
Short term investments 45,115,391 44,254,862
Accounts receivable 4,663,282 3,810,792
Income tax receivable 290,205 494,711
Deferred royalty buy-down 1,535,274 1,451,893
Prepaid expenses and other current assets 800,547 624,345
Total current assets 58,434,663 55,399,967
Long-term investments 7,396,902 3,771,380
Deferred royalty buy-down - long term, net 1,156,242 1,976,456
Deferred tax assets, net 3,072,116 3,290,122
Patent costs, net 238,030 258,355
Total assets 70,297,953 64,696,280
Current liabilities:    
Accounts payable and accrued expenses 1,162,497 738,649
Deferred revenue 1,298,912 1,179,848
Accrued liabilities of discontinued operations 78,138 78,138
Total current liabilities 2,539,547 1,996,635
Long-term deferred revenue 5,661,179 6,417,702
Stockholders' equity:    
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding 0 0
Common stock, $.001 par value; 10,000,000 shares authorized; 7,575,167 and 7,555,167 shares issued, 7,166,998 and 7,156,281 shares outstanding as of June 30, 2017 and December 31, 2016, respectively 7,575 7,555
Additional paid-in capital 33,270,422 32,945,240
Retained earnings 36,579,693 30,610,849
Treasury stock, 408,169 and 398,886 shares at cost as of June 30, 2017 and December 31, 2016, respectively (7,760,463) (7,281,701)
Total stockholders' equity 62,097,227 56,281,943
Total liabilities and stockholders' equity $ 70,297,953 $ 64,696,280